Twist Bioscience Corporation

Twist Bioscience Corporation

$46.34
-0.06 (-0.13%)
NASDAQ Global Select
USD, US
Medical - Diagnostics & Research

TWST Price Chart

Basic
Market Cap$2.36B
Price$46.9
52 Week Range18.8-60.9
Beta1.78
Margins
Gross Profit Margin42.61%
Operating Profit Margin-70.56%
Net Profit Margin-66.69%
Valuation (TTM)
P/E Ratio-13.00
Price to Sales Ratio8.79
Price to Book Ratio5.74
PEG Ratio-2.26

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Full-Time Employees

919

IPO Date

2018-10-31T00:00:00.000Z

Description

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Phone

800 719 0671

Address

681 Gateway Boulevard, South San Francisco, CA, 94080, US

CIK

0001581280